Farms.com Home   News

POTENTIAL FOR JEV IN US LEADS TO USDA STATEMENT ON PREPAREDNESS AND TESTING

The US swine industry, including the Swine Health Information Center, continues to prepare for the possible incursion of Japanese encephalitis virus in pigs. The threat of JEV has prompted the USDA APHIS Veterinary Services division to issue a statement regarding related testing and preparedness. The statement also addresses the diagnostic submission process and USDA plans for further preparedness activities.  

Diagnostic testing for any animals with clinical signs suggesting of Japanese encephalitis virus (JEV) is available at no cost to animal owners and producers at the National Veterinary Services Laboratories (NVSL) in Ames, Iowa. Veterinarians and producers must first notify their State or Federal Animal health officials if JEV is on a differential list, and these officials will assist in the submission and sampling as needed. NVSL uses both PCR and sequencing to identify and confirm the virus. While serology has proven useful in the surveillance and diagnosis of JEV in endemic countries, it is of limited use in JEV free countries and will not be offered as an on-demand diagnostic test at NVSL at this time. USDA scientists are actively collaborating with partners to develop and characterize additional diagnostics, and in the future USDA will expand their active JEV research program to the National Bio and Agro-Defense Facility, once the facility is fully operational, to better understand the pathogenesis, evolution and epidemiology of JEV.  

USDA APHIS Veterinary Services 

October 2023 

Contact information for the diagnostic virology laboratory at the National Veterinary Services Laboratory is 515-337-7551 or NVSL.DVL.TeamLeads@usda.gov. 

The US is considered a geographic region at risk for the introduction of Japanese encephalitis, a disease capable of affecting humans as well as pigs. JE is transmitted primarily by Culex mosquitoes infected with the virus. Environmental conditions similar to JEV endemic countries, as well as the availability of susceptible hosts and vectors, create concern for the US pork industry and public health officials. Clinical signs of JEV in the breeding herd includes reproductive failure, delayed farrowing, stillbirths, mummified fetuses, abortions, and weak or shaker piglets. 

One of SHIC’s JEV preparedness efforts was the implementation of a systematic literature review led by researchers at Kansas State University to increase understanding of the virus’s biology, components and dynamics of transmission, and environmental factors necessary for incursion and establishment. The same team at KSU is also re-assessing potential pathways of JEV introduction into the US via a risk assessment with funding provided by SHIC. Along with the Center for the Ecology of Infectious Disease at the University of Georgia, researchers at KSU, and the USDA National Bio and Agro-Defense Facility, Foreign Arthropod-Borne Animal Diseases Research Unit are studying the spread of JEV in Australia (2022) to help inform and model the potential spread in the US, should there be a JEV incursion.  

Click here to see more...

Trending Video

PRRS Eradication Strategies - Dr. DeBuse and Dr. Tousignant

Video: PRRS Eradication Strategies - Dr. DeBuse and Dr. Tousignant


In this episode of The Swine it Podcast Show, Dr. Neil DeBuse from Kalmbach Feeds and Dr. Steve Tousignant from Vaxxinova US discuss PRRS management strategies, recombination risks, whole genome sequencing, and the role of autogenous immunization programs in swine systems. They highlight practical approaches to improving immunity, reducing outbreaks, and advancing PRRS control across production systems. Listen now on all major platforms!

"Being PRRS negative sooner is a real key for eradication because every additional positive week increases production losses and viral exposure risks." - Dr. Neil DeBuse

Meet the guest: Dr. Neil DeBuse is a veterinarian at Kalmbach Feeds with more than 30 years of experience in swine health and production. His work focuses on PRRS control, biosecurity, immunity, and improving production stability across commercial swine systems in the United States and internationally.

Dr. Steve Tousignant is Director of the Swine Business Unit and Technical Services Veterinarian at Vaxxinova US, with a DVM and PhD from the University of Minnesota. His experience combines epidemiology, technical services, and practical immunization strategies designed to support consistent herd performance and long-term production stability. Don’t miss the chance to be part of the Swine Inner Circle!